RecruitingNot ApplicableNCT06268431

Oxytocin Rest to Reduce Cesarean Delivery

Oxytocin Rest to Reduce Cesarean Delivery in Prolonged Labor: An Open-Label, Randomized Controlled Trial


Sponsor

Christiana Care Health Services

Enrollment

350 participants

Start Date

Mar 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Prolonged labor is usually managed with continuous oxytocin infusion. "Oxytocin rest" has been proposed as a strategy to resolve protracted labor in patients who have received continuous oxytocin without progress. This strategy involves discontinuing oxytocin then restarting infusion after a period of time, under the theory that washout of the oxytocin receptor will strengthen uterine contractions to improve labor progress. "Oxytocin rest" is performed on labor and delivery units across the United States. Yet, there is no randomized or prospective data to support the practice. The purpose of this study is to assess whether oxytocin rest of 60 minutes in patients with prolonged labor reduces risk for cesarean delivery.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Inclusion Criteria4

  • ≥18 years of age
  • Singleton gestation in vertex presentation
  • ≥36 weeks gestation
  • Prolonged latent labor, defined as cervical dilation \<6cm after ≥8 hours since rupture of membranes and on continuous oxytocin

Exclusion Criteria8

  • Not meeting the above criteria
  • Any contraindication to continuous oxytocin at time of randomization
  • Cesarean section anticipated by the clinical team at time of randomization (for any reason excepting labor dystocia)
  • \>18 hours between rupture of membranes and randomization
  • Known intraamniotic infection at randomization
  • Fetal demise
  • Any contraindication to vaginal delivery
  • Maternal eclampsia

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROxytocin rest

60-minute oxytocin rest


Locations(1)

ChristianaCare Health System

Newark, Delaware, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06268431


Related Trials